U.S. President Donald Trump Threatens India of Retaliation if India doesn’t allow exports of the drugs linked to COVID-19 treatment.
“If he (PM Narendra Modi) doesn’t allow it to come out, That would be ok. But of course, there may be retaliation. Why wouldn’t there be? “
Donald Trump said in a press conference responding to the question about India’s ban on the export of malaria’s drug to the United States.
US President Donald Trump has said he would be surprised if India did not allow the export of Hydroxychloroquine tablets to the United States despite a request made to New Delhi over the subject.
HIGHLIGHTS
- Trump has threatened India by saying that if India does not release Hydroxychloroquine ordered by India, there may be retaliation
- India’s decision to ban the exports of Hydroxychloroquine is driven by its desire to take stock of the domestic requirements
- Hydroxychloroquine tablet is used to prevent and treat malaria, lupus and rheumatoid arthritis, among other ailments.
US President Donald Trump has said that if India does not allow export of anti-malaria drug Hydroxychloroquine to the US, as requested, there may be retaliation.
Last week Trump said that he has sought help from Prime Minister Narendra Modi to allow the sale of Hydroxychloroquine tablets ordered by the US to treat the growing number of coronavirus patients in his country, hours after India banned the export of the anti-malarial drug.
He has said he would be surprised if India did not allow the export of Hydroxychloroquine tablets to the United States.
“So, I would be surprised if that were his decision. He’d have to tell me that. I spoke to him Sunday morning, called him, and I said we’d appreciate your allowing our supply to come out. If he doesn’t allow it to come out, that would be okay, but of course, there may be retaliation. Why wouldn’t there be?” Trump said.
Trump’s statement threatening India of Retaliation sent shock waves on social media and people started trolling Indian prime minister Narendra Modi. See the Tweets by some Twitter users, below.
Hydroxychloroquine tablet is used to prevent and treat malaria, lupus and rheumatoid arthritis, among other ailments.
The drug is seen as to offer a viable therapeutic solution to coronavirus that has so far taken the lives of more than 10,000 Americans and infected over 3.6 lakhs, just in a matter of weeks.
Last month, India imposed a ban on export on Hydroxychloroquine, on which Trump is now banking heavily in the treatment of Covid-19 patients.
India has received similar requests from several other countries including its immediate neighbours like Sri Lanka and Nepal. India has said that it is reviewing its export ban order.
Notably, India’s decision to ban the exports of Hydroxychloroquine is driven by its desire to take stock of the domestic requirements and ensure that the country has enough in its kitty.
Notably, India’s decision to ban the exports of Hydroxychloroquine is driven by its desire to take stock of the domestic requirements and ensure that the country has enough in its kitty.
Reiterating that for many years, India has been taking advantage of the US on trade, Trump said that he would be surprised if New Delhi was to stop export of Hydroxychloroquine to the US.
India Allows Export of Drugs Linked to Covid-19 Treatment to “Badly-Hit” Countries
India has agreed to ship Hydroxychloroquine [HCQ] to the nations most impacted by Covid-19 and urged not to “politicize” the issue after US President Donald Trump threatened “retaliation” for its drug export ban.
![India has agreed to ship Hydroxychloroquine [HCQ] to the nations most impacted by Covid-19 and urged not to “politicize” the issue after US President Donald Trump threatened “retaliation” for its drug export ban.](https://i2.wp.com/www.newpakweb.com/wp-content/uploads/2020/04/India-allows-export-of-malaria-drug-to-US.jpg?fit=696%2C364&ssl=1)
“In view of the humanitarian aspects (And actually after the Trump’s statement of Retaliation against India) of the pandemic, it has been decided that India would license paracetamol and hydroxychloroquine in appropriate quantities to all our neighboring countries dependent on our capabilities,” Foreign Ministry spokesperson Anurag Srivastava said on Tuesday.
We will also be supplying these essential drugs to some nations who have been particularly badly affected by the pandemic.
Srivastava warned against “any speculation in this regard or any attempts to politicize the matter.”
The anti-malarial drug HCQ is currently under clinical trial as a possible treatment for the coronavirus. It is among the drugs the World Health Organization [WHO] is looking at as a promising therapy for the disease.
Over the weekend, India banned the shipping of the drug overseas. Trump criticized this move, warning that New Delhi may face “retaliation” unless it reverses the export ban.
During his daily press briefings, Trump, too, has touted hydroxychloroquine as a possible cure for Covid-19. The US has the largest number of confirmed Covid-19 cases in the world, with more than 368,000 people testing positive for the disease, according to a tally by Johns Hopkins University. More than 10,000 patients have died.
Conclusion
- On 4th April, India banned export of hydroxychloroquine which is anti-malaria drug and is helpful in curing Covid19 Coronavirus.
- On 6th April Trump threatened retaliation against India if they don’t allow export.
- On 7th Apr, Modi Govt has allowed export of the medicine.